Duck viral enteritis virus detection kit and its application

A chemiluminescent ELISA antibody detection kit prepared using gB and gC proteins solves the problems of long detection time and expensive equipment in existing duck viral enteritis detection, achieving rapid detection with high sensitivity and specificity, supporting the prevention and control of duck viral enteritis and the development of animal husbandry.

CN118067990BActive Publication Date: 2024-11-12BEIJING YISEN BIOTECH
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410164640.X
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-02-05
Publication Date
2024-11-12
Estimated Expiration
2044-02-05

AI Technical Summary

Technical Problem

Existing methods for detecting duck viral enteritis virus are time-consuming, cumbersome, or require expensive instruments and skills, making it difficult to meet the needs of large-scale sample testing, and there is a lack of effective diagnostic kits.

Method used

Using gB and gC proteins as antigens, an ELISA antibody detection kit was prepared based on chemiluminescent immunoassay. The kit was then used for detection with specific buffer and enzyme-labeled secondary antibody to achieve high sensitivity and high specificity.

Benefits of technology

It enables rapid and convenient detection of duck viral enteritis virus in large quantities, with high sensitivity and specificity. It is applicable to the detection of vaccine products, blood products and poultry processed products, supporting the prevention and control of duck viral enteritis and the development of animal husbandry.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004699388670000101
    Figure BDA0004699388670000101
  • Figure BDA0004699388670000111
    Figure BDA0004699388670000111
  • Figure BDA0004699388670000112
    Figure BDA0004699388670000112
Patent Text Reader

Abstract

The present invention relates to the field of biological detection technology, and in particular to a duck viral enteritis virus detection kit and application. The antigenic proteins coated in the kit of the present invention are gB protein and gC protein. The gB protein and the gC protein are the main structural proteins of IBDV. The present invention mixes the gB protein and the gC protein for coating, and based on the chemiluminescent immunoassay method, antibodies can be accurately detected in the early stage of duck viral enteritis infection, and the sensitivity is high, the sensitivity and specificity are strong, and the stability is good, which is of great significance to the prevention and control of duck viral enteritis and the development of animal husbandry.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of biological detection, and in particular to a duck viral enteritis virus detection kit and application thereof. Background Art

[0002] Duck Viral Enteritis (DVE), also known as duck plague (DP), is an acute, highly contagious disease caused by duck viral enteritis virus (DEV) in ducks. It is common in Anseriformes such as ducks, geese, and swans, and is one of the most serious diseases that harms the waterfowl farming industry worldwide. The duck viral enteritis virus is constantly mutating, which brings many inconveniences to prevention and control work. There is an urgent need to establish effective and reliable monitoring methods so that the health status and immune antibody levels of ducks can be understood in a timely and correct manner.

[0003] Although there are many diagnostic methods for duck viral enteritis at home and abroad, there are few diagnostic methods that can be applied clinically. The classic serum neutralization test is an accurate method, but it is time-consuming (about 1-2 weeks) and laborious, and is not suitable for the detection of large quantities of serum samples; although the virus isolation and identification and virus neutralization tests are highly accurate, the experimental cycle is long and the operation is cumbersome, and they are not suitable for the detection of large quantities of samples. The conventional PCR and fluorescent quantitative PCR methods developed in modern times require more expensive instruments, reagents and good operating skills, and are currently only used for scientific research. The ELISA method can meet the quarantine needs of grassroots units with its advantages such as sensitivity, specificity, rapidity, simple operation, easy standardization, and suitability for the detection of large numbers of animal groups. Therefore, it has always been the preferred method for detecting various animal diseases. Although there have been some reports on the establishment of ELISA diagnostic methods for duck viral enteritis at home and abroad, the previously established ELISA diagnostic methods still have many areas that need to be improved, and there is still no diagnostic kit available.

[0004] In view of this, the present invention is proposed. Summary of the invention

[0005] In view of the technical problems existing in the background technology, the present invention provides a duck viral enteritis virus detection kit and application.

[0006] Specifically, the technical solution provided by the present invention is as follows:

[0007] In a first aspect, the present invention provides the use of gB protein and gC protein in the preparation of a duck viral enteritis virus detection kit, wherein the gB protein is obtained by gene expression of the nucleotide sequence shown in SEQ ID NO.1; and the gC protein is obtained by gene expression of the nucleotide sequence shown in SEQ ID NO.2.

[0008] The DNA of duck viral enteritis virus has the typical characteristics of α-herpesvirus. The genome is a non-segmented, double-stranded linear DNA with a size of about 150kb. The entire genome consists of a covalently linked unique long region (UL) and a unique short region (US). The two segments of US are terminal repeats and inverted repeats. The viral genome is named UL1, UL2, US1, US2, etc. The gB protein is located in the UL27 region and is an envelope glycoprotein encoded by the UL27 gene. It plays an important role in plasma membrane fusion and virus release. It is highly conserved and shows partial cross-complementarity between different α-herpesviruses. It has good reactogenicity and immunogenicity and can induce the body to produce high levels of humoral and cellular immune responses. The gC protein is a multifunctional glycoprotein encoded by the UL44 gene. It participates in the adsorption and release of the virus and can maintain the stability of the virus. It is related to the virulence of the virus and can participate in lymphocyte proliferation, CTL, complement-mediated neutralization, etc., inducing the host to produce humoral and cellular immune responses. The invention mixes and coats the gB protein and the gC protein, and can accurately detect antibodies in the early stage of duck viral enteritis infection based on a chemiluminescent immunoassay method, with high sensitivity, strong sensitivity and specificity, and good stability, which is of great significance to the prevention and control of duck viral enteritis and the development of animal husbandry.

[0009] Preferably, the duck viral enteritis virus detection kit is a chemiluminescent ELISA antibody detection kit, comprising a coating solution, wherein the coating solution uses a carbonate buffer with a pH value of 9.2-9.8 as a base solvent, and the added antigen consists of 0.9-1.1 μg / ml of gB protein and 0.9-1.1 μg / ml of gC protein. More preferably, the coating solution uses a carbonate buffer with a pH value of 9.6 as a base solvent, and the added antigen consists of 1.0 μg / ml of gB protein and 1.0 μg / ml of gC protein. An antigen coating concentration of 1 μg / ml has the best effect on the light index and signal-to-noise ratio performance in subsequent optical detection.

[0010] Preferably, the expression method of the gB protein comprises: inserting the gene of the nucleotide sequence shown in SEQ ID No.1 into a prokaryotic vector to obtain a recombinant vector; transforming the recombinant vector into Escherichia coli BL21 (DE3) to obtain a recombinant bacterium; the expression method of the gC protein comprises: inserting the gene of the nucleotide sequence shown in SEQ ID No.2 into a prokaryotic vector to obtain a recombinant vector; transforming the recombinant vector into Escherichia coli BL21 (DE3) to obtain a recombinant bacterium. The nucleotide sequences shown in SEQ ID No.1 and SEQ ID No.2 are optimized Escherichia coli preferred codon sequences, which can express gB protein and gC protein in a soluble form in Escherichia coli BL21 (DE3), increase the protein expression amount, and make the obtained gB protein and gC protein have high concentration, high purity, high activity and high stability; the detection results for the coated plate show that its sensitivity and specificity are good.

[0011] In a second aspect, the present invention provides a detection kit for duck viral enteritis virus, comprising a coating solution, wherein the coating solution is based on a carbonate buffer solution with a pH value of 9.2-9.8, and the added antigens are composed of 0.9-1.1 μg / ml of gB protein and 0.9-1.1 μg / ml of gC protein; preferably, the coating solution is based on a carbonate buffer solution with a pH value of 9.6, and the added antigens are composed of 1.0 μg / ml of gB protein and 1.0 μg / ml of gC protein. The gB protein is obtained by gene expression of the nucleotide sequence shown in SEQ ID NO.1; the gC protein is obtained by gene expression of the nucleotide sequence shown in SEQ ID NO.2.

[0012] Preferably, the detection kit further comprises one or more of a coating plate, an enzyme-labeled secondary antibody, a sample diluent, a positive control serum, a negative control serum, a luminescent substrate and a washing solution.

[0013] The present invention utilizes the coated antigen to prepare a microplate kit based on a chemiluminescent immunoassay method, which can perform detection more accurately, more sensitively and more efficiently, and is of great significance for preventing and controlling the infection and epidemic of duck viral enteritis virus.

[0014] Preferably, the enzyme-labeled secondary antibody of the present invention is preferably a secondary antibody labeled with horseradish peroxidase. In a preferred embodiment of the present invention, the enzyme-labeled secondary antibody is a goat anti-duck IgG antibody labeled with horseradish peroxidase.

[0015] Preferably, the sample diluent of the present invention is a phosphate buffer containing casein and Tween-20; based on the volume of the phosphate buffer as 100 vol%, the casein content is preferably 0.4-0.6 vol%, more preferably 0.5 vol%; the Tween-20 content is preferably 0.4-0.6 vol%, more preferably 0.5 vol%.

[0016] Preferably, the luminescent substrate of the present invention comprises a luminescent substrate A and a luminescent substrate B; the luminescent substrate A is based on a Tris buffer solution with a pH value of 7.5-8.5 and a concentration of 0.04-0.06 mol / L, and is added with 0.08-0.12 mmol / L of luminol and 0.08-0.12 g / L of hydroxycoumarin; the luminescent substrate B is based on an ammonium acetate solution with a pH value of 5.0-5.5 and a concentration of 0.04-0.06 mol / L, and is added with 0.06-0.08 mmol / L of vitamin C and 2.7-3.3 mmol / L of amino acid oxidase. More preferably, the luminescent substrate A uses Tris buffer with a pH value of 8.0 and a concentration of 0.05 mol / L as the base solvent, and adds 0.1 mmol / L luminol and 0.1 g / L hydroxycoumarin; the luminescent substrate B uses ammonium acetate solution with a pH value of 5.2 and a concentration of 0.05 mol / L as the base solvent, and adds 0.07 mmol / L vitamin C and 3.0 mmol / L amino acid oxidase.

[0017] Preferably, the washing solution of the present invention comprises 0.018-0.022 mol / L of sodium dihydrogen phosphate, 0.07-0.09 mol / L of sodium dihydrogen phosphate, 1.29-1.45 mol / L of sodium chloride and 0.4-0.6 vol% of Tween-20 based on a 10-fold concentration; more preferably, the washing solution comprises 0.02 mol / L of sodium dihydrogen phosphate, 0.08 mol / L of sodium dihydrogen phosphate, 1.37 mol / L of sodium chloride and 0.5 vol% of Tween-20 based on a 10-fold concentration; the pH value of the washing solution is preferably 7.3-7.5, more preferably 7.4 based on a 10-fold concentration.

[0018] In a third aspect, the present invention also provides the use of the detection kit in the detection of duck viral enteritis virus for non-disease diagnosis purposes, and the application includes detecting whether vaccine products, blood products or poultry processed products contain duck viral enteritis virus.

[0019] Preferably, the application comprises the following steps:

[0020] S1. After the sample is diluted with sample diluent, it is added to the coated plate for reaction;

[0021] S2, washing the coated plate after the reaction in step S1 with a washing solution, adding an enzyme-labeled secondary antibody, and incubating;

[0022] S3, washing the coated plate after incubation in step S2 with a washing solution, adding a luminescent substrate, and detecting the luminescence value using a chemiluminescent immunoassay detection instrument;

[0023] S4. According to the luminescence value obtained in step S3, judging whether the test sample contains duck viral enteritis virus;

[0024] Among them, the dilution multiple described in step S1 is preferably 100-fold dilution. The 100-fold diluted sample has the best effect in the light index and signal-to-noise ratio performance in subsequent optical detection. The temperature of the reaction in step S1 is preferably 36-38°C, more preferably 37°C; the reaction time is preferably 10-30min, more preferably 15-20min, more preferably 15min. The incubation temperature in step S2 is preferably 36-38°C, more preferably 37°C; the incubation time is preferably 10-30min, more preferably 15-20min, more preferably 15min. The reaction temperature after adding the luminescent substrate in step S3 is preferably 15-25°C; the reaction time is preferably 5-6min, more preferably 5min; after the reaction is completed, the luminescence value is detected using a chemiluminescence immunoassay detection instrument.

[0025] The determination method in step S4 includes:

[0026] The S / P value was calculated according to the formula: S / P value = (luminescence value of the test sample - luminescence value of the negative control serum sample) / (luminescence value of the positive control serum sample - luminescence value of the negative control serum sample);

[0027] If the S / P value is less than 0.47, it is determined that the sample does not contain duck viral enteritis virus; if the S / P value is ≥ 0.47, it is determined that the sample contains duck viral enteritis virus.

[0028] Beneficial effects:

[0029] The present invention provides a duck viral enteritis virus detection kit and application. The antigenic proteins coated by the kit are gB protein and gC protein. The gB protein and gC protein are the main structural proteins of IBDV. The gB protein is a highly conserved protein in the herpes virus family. It has the highest content in infected cells and has strong immunogenicity. It can induce the body to produce neutralizing antibodies and cellular immune responses. The gC protein is located on the surface of the mature virus particle envelope, constitutes the virus particle antigenic determinant cluster, can fully induce the host immune response, and participate in humoral immunity and lymphocyte immunity. The present invention mixes the gB protein and the gC protein for coating. Based on the chemiluminescent immunoassay method, antibodies can be accurately detected in the early stage of duck viral enteritis infection, and the sensitivity is high, the sensitivity and specificity are strong, and the stability is good. It is of great significance to the prevention and control of duck viral enteritis and the development of animal husbandry.

[0030] At the same time, the gene of the nucleotide sequence shown in SEQ ID No.1 and SEQ ID No.2 of the present invention can make gB protein and gC protein express through prokaryotic expression system, gB protein and gC protein are directionally cloned into expression vector pET32a, transformed into competent E.coli BL21 (DE3), and after optimizing culture time, induction temperature, IPTG concentration, induction time, gB protein and gC protein are expressed in soluble form and the expression amount of gB protein and gC protein is increased. The obtained gB protein and gC protein have higher activity and stability, which helps to improve the detection sensitivity of the kit.

[0031] In addition, the present invention also establishes a chemiluminescent immunoassay method for detecting duck viral enteritis virus using the gB protein and gC protein as a joint coating antigen. The method has no background fluorescence and can detect extremely low concentrations of analytes within a wide linear range. Moreover, antibodies can be accurately detected in the early stages of duck viral enteritis infection, which is of great significance to the prevention and control of duck viral enteritis and the development of animal husbandry.

[0032] The present invention provides a rapid and simple serological diagnosis method for antibody monitoring and epidemiological investigation of immune ducks, provides technical support for the prevention and treatment of duck viral enteritis, provides technical support for the purification of SPF duck population diseases, and lays a foundation for the development of diagnostic kits. DETAILED DESCRIPTION

[0033] The technical solutions provided by the present invention are described in detail below in conjunction with the examples, but they should not be understood as limiting the scope of protection of the present invention. Unless otherwise specified, the experimental methods used in the examples are conventional methods; the materials and reagents used can be obtained from commercial sources.

[0034] Example 1

[0035] This embodiment provides a duck viral enteritis virus chemiluminescent ELISA antibody detection kit, which includes a chemiluminescent antigen coated plate, an enzyme-labeled antibody, a serum diluent, a positive control serum, a negative control serum, a luminescent substrate A, a luminescent substrate B and a 10-fold concentrated washing solution.

[0036] The chemiluminescent antigen coating plate is a milky white opaque polystyrene 96-well plate, which is mixed with the gB protein and gC protein of duck viral enteritis virus. The coating process is as follows: the gB protein and gC protein of duck viral enteritis virus are added to a carbonate buffer solution with a pH of 9.6, so that the concentrations of gB protein and gC protein are both 1ug / mL, and the protein coating solution is added to the chemiluminescent plate at a sample volume of 100uL / well. Incubate at 2-8°C for 16-18h; shake off the protein coating solution in the chemiluminescent plate, add 150uL / well of 5% BSA-PBST to each well for blocking, and block at 37°C for 2h; shake off the blocking solution in the chemiluminescent plate, dry at 25°C for 2h, put in a desiccant, seal and package, and store at 2-8°C.

[0037] The gB protein is a recombinant protein, and the method of obtaining is: gB protein (its nucleotide sequence is shown in SEQ ID NO.1) is directed cloned into the expression vector pET32a, and transformed into competent E.coli BL21 (DE3). In this embodiment, the cloned positive bacteria are induced with different concentrations of IPTG and different times. The results show that the expression level is the highest when 0.4mmol / L IPTG is induced and cultured, and the protein expression levels at different induction times are not much different. It is determined that when OD is 0.6 at 37°C, 0.4mmol / L IPTG is added, and the induction culture is induced for 3h as the optimal induction time for positive bacteria. After optimizing the culture time, induction temperature, IPTG concentration, and induction time, the gB protein is expressed in a soluble form and the expression level of the gB protein is increased. This example further uses a nickel column affinity chromatography purification method to separate the soluble supernatant from the recombinant protein expressed by Escherichia coli after ultrasonic disruption to purify the protein. By comparing the effects of different buffers and pH values ​​on the nickel column affinity chromatography protein, it is finally determined that the gB protein recovered under the condition of PBS+100mmol / L imidazole pH=7 has a higher purity. This example optimizes the elution buffer components, reagent concentrations, and the purification, dialysis, and concentration process to obtain a gB protein with high concentration, high purity, good activity, and good stability. The results of the test using the protein coated plate show that the sensitivity and specificity are good.

[0038] The gC protein is a recombinant protein, which is obtained by cloning the gC protein (its nucleotide sequence is shown in SEQ ID NO.2) into the expression vector pET32a and transforming it into competent E. coli BL21 (DE3). In order to maximize the protein expression, this example explored different IPTG concentrations, induction time, induction temperature and culture time during expression. After a certain culture time, the OD value of the bacterial solution was detected by ultraviolet spectrophotometer until the OD value of the bacterial solution was 0. 600 The value was between 0.4 and 0.6, and the bacterial solution was divided into bacterial bottles, and IPTG with concentrations of 0.1mmol / L, 0.2mmol / L, 0.4mmol / L, 0.6mmol / L, 0.8mmol / L, 1.0mmol / L, 1.2mmol / L and 1.5mmol / L was added, respectively, and induced at 37℃ for 1h, 2h, 3h, 4h, 5h and 6h, respectively. The highest expression of soluble protein under different time lengths was compared, and it was found that the highest expression of soluble protein was found when 1.0mmol / L was induced at 37℃ for 4h. Finally, the optimal expression conditions of recombinant gC protein in soluble form were determined: IPTG concentration was 1.0mmol / L, and induced at 37℃ for 4h. After optimizing the culture time, induction temperature, IPTG concentration and induction time, gC protein was expressed in soluble form and the expression of gC protein was increased. This example further uses a nickel column affinity chromatography purification method to separate the soluble supernatant from the recombinant protein expressed by Escherichia coli after ultrasonic disruption to purify the protein. By comparing the effects of different buffers and pH values ​​on the nickel column affinity chromatography protein, it is finally determined that the gC protein recovered under the condition of PBS+100mmol / L imidazole pH=7 has a higher purity. This example optimizes the elution buffer components, reagent concentrations, and the purification, dialysis, and concentration process to obtain a gC protein with high concentration, high purity, good activity, and good stability. The results of the test using this protein coated plate show good sensitivity and specificity.

[0039] The serum diluent was phosphate buffer containing 5% (v / v) casein and 0.5% (v / v) Tween-20, pH = 7.4.

[0040] The luminescent substrate A contains 0.1 mmol / L luminol and 0.01% hydroxycoumarin by volume; the solvent is 0.05 mol / L Tris buffer at pH=8.0;

[0041] The luminescent substrate B contains 0.07 mmol / L vitamin C and 3 mmol / L amino acid oxidase, and the solvent is 0.05 mol / L ammonium acetate solution with a pH of 5.2.

[0042] The 10-fold concentrated washing solution is 0.02 mol / L sodium dihydrogen phosphate, 0.08 mol / L sodium dihydrogen phosphate, 1.37 mol / L sodium chloride and 0.5% (v / v) Tween-20, pH=7.4.

[0043] This embodiment also provides a method for detecting using the duck viral enteritis virus chemiluminescent ELISA antibody detection kit, and the detection steps are as follows:

[0044] The serum to be tested was diluted 1:100 times with serum diluent, and 100uL was added to the chemiluminescent antigen coated plate, and duck viral enteritis virus positive control serum and negative control serum were set as controls. The chemiluminescent antigen coated plate was reacted at 37°C for 15 minutes; washed 5 times with washing solution, and sheep anti-duck IgG antibody labeled with horseradish peroxidase diluted 10,000 times with 5% BSA-PBST was added, and incubated at 37°C for 15 minutes; washed 5 times with washing solution, luminescent substrate A and luminescent substrate B were added, reacted at 15-25°C for 5 minutes, and the luminescence value was detected with a chemiluminescent immunoassay detection instrument.

[0045] Example 2

[0046] Establishment of chemiluminescent ELISA antibody detection kit for duck viral enteritis virus:

[0047] The optimal coating concentration and the dilution multiple of goat anti-duck IgG labeled with horseradish peroxidase were determined by the chessboard titration method. The gB protein and gC protein were made into gradients of 2ug / ml, 1ug / ml, 0.5ug / ml, 0.25ug / ml and 0.1ug / ml respectively and mixed for coating. The duck viral enteritis positive control and negative control serum were diluted 1:100 times respectively. The enzyme-labeled antibody dilution multiples were 1:1000, 1:2000, 1:5000, 1:10000, and 1:20000. Through chessboard cross detection, according to the signal-to-noise ratio of the positive control and the negative control, the final coating conditions were determined to be 1ug / ml for the gB protein and gC protein coating concentration. The dilution multiple of the goat anti-duck IgG antibody labeled with horseradish peroxidase was 1:10000.

[0048] Example 3

[0049] The critical value of the duck viral enteritis virus chemiluminescent ELISA antibody detection kit is determined by using the kit of the present invention to detect serum with a known background.

[0050] The kit was used to detect 60 duck viral enteritis positive samples and 180 negative samples, and the S / P value of each sample was calculated. The S / P value of all serum samples was analyzed using SPSS16.0 software. The ROC curve was constructed using a non-parametric method, and the cut-off point with the maximum Youden index was used as the critical point for positive and negative judgment. The sensitivity and specificity of the kit were also determined. Finally, the judgment standard of this kit was set as: S / P value <0.47, the sample was judged as antibody negative; S / P value ≥0.47, the sample was judged as duck viral enteritis antibody positive. Under this judgment standard, the sensitivity of duck viral enteritis antibody detection corresponding to the critical value was 95.67%, and the specificity was 93.29%, which proved that the accuracy of this diagnostic method was high and the kit had a high diagnostic value.

[0051] Example 4

[0052] Duck viral enteritis virus chemiluminescent ELISA antibody detection kit sensitivity and specificity detection:

[0053] The positive serum of duck viral enteritis virus was diluted with serum diluent in multiple ratios, and the gradient was 1:32, 1:64, 1:128, 1:256, 1:512, 1:1024, 1:2048, and the diluted samples were directly tested. The positive serum of duck Tembusu disease, duck viral hepatitis, duck influenza and Riemerella anatipestifer were diluted 1:100 times, and the diluted samples were directly tested. At the same time, positive control serum and negative control serum were set as controls. The diluted samples were added to the chemiluminescent antigen-coated plate and reacted at 37℃ for 15min; washed 5 times with washing solution, added with horseradish peroxidase-labeled goat anti-duck IgG antibody diluted 10000 times with 5% BSA-PBST, and incubated at 37℃ for 15min; washed 5 times with washing solution, added luminescent substrate A and luminescent substrate B, reacted at 15-25℃ for 5min, and the luminescence value was detected by chemiluminescent immunoassay detection instrument. The test results are evaluated using the S / P value, and the S / P formula is as follows: S / P = (luminescence value of the test sample - luminescence value of the negative control serum sample) / (luminescence value of the positive control serum sample - luminescence value of the negative control serum sample).

[0054] Results: The duck viral enteritis virus chemiluminescent ELISA antibody detection kit of the present invention has good sensitivity, and the dilution of duck viral enteritis detection can reach 1:1024. The duck viral enteritis virus chemiluminescent ELISA antibody detection kit of the present invention has good specificity, and has no cross reaction with the above-mentioned duck Tembusu disease positive serum, duck viral hepatitis positive serum, duck influenza positive serum and duck plague Riemerella anatipestifer disease positive serum. Therefore, the chemiluminescent kit of the present invention has high sensitivity and strong specificity. The specific results are shown in Table 1.

[0055] Table 1 Sensitivity and specificity results

[0056]

[0057]

[0058] Example 5

[0059] Duck viral enteritis virus chemiluminescent ELISA antibody detection kit repeatability test:

[0060] Five positive and negative sera with clear background were repeated five times on the same chemiluminescent antigen-coated plate, and the intra-batch coefficient of variation (CV) was calculated. At the same time, the five sera with clear background were repeated on three different batches of chemiluminescent antigen-coated plates, and the inter-batch coefficient of variation (CV) was calculated. The results showed that both the intra-batch and inter-batch CVs were less than 10%, with good repeatability. The specific results are shown in Table 2.

[0061] Table 2 Repeatability results

[0062]

[0063] Example 6

[0064] Stability test of duck viral enteritis virus chemiluminescent ELISA antibody detection kit:

[0065] In order to test the stability and shelf life of the kit, the kit was placed at 2-8°C and taken out at 1, 3, 6, 9, 12 and 15 months for sensitivity and specificity tests. The results showed that at the 15th month, the sensitivity and specificity test results of the kit were normal. Therefore, the kit can be stably stored at 2-8°C for 15 months, and the chemiluminescence kit has good stability.

[0066] Example 7

[0067] Comparison of the test results of duck viral enteritis virus chemiluminescent ELISA antibody detection kit and self-built duck viral enteritis virus antibody ELISA kit on known duck hepatitis virus antibody positive samples:

[0068] The self-built duck viral enteritis virus antibody ELISA kit comprises an antigen coating plate, an enzyme-labeled antibody, a serum diluent, a positive control serum, a negative control serum, a color developing solution, a stop solution and a 10-fold concentrated washing solution.

[0069] The antigen coating plate is a transparent polystyrene 96-well plate, which is mixed with the gB and gC proteins of duck viral enteritis virus (the preparation method is the same as in Example 1). The coating process is as follows: the gB protein and gC protein of duck viral enteritis virus are added to a carbonate buffer solution at pH = 9.6, so that the concentrations of the gB protein and the gC protein are both 0.5ug / mL (on a self-built ELISA system, the coating concentration is tested by gradient detection of 2ug / ml, 1ug / ml, 0.5ug / ml, 0.25ug / ml and 0.1ug / ml, and 0.5ug / ml is optimal), and the protein coating solution is added to the antigen plate with a sample volume of 100uL / well. Incubate at 2-8℃ for 16-18h; shake off the protein coating solution in the coating plate, add 150uL / well of 5% BSA-PBST to each well for blocking, and block at 37℃ for 2h; shake off the blocking solution in the coating plate, dry at 25℃ for 2h, put in desiccant, seal and store at 2-8℃.

[0070] The serum diluent was phosphate buffer containing 5% (v / v) casein and 0.5% (v / v) Tween-20, pH = 7.4.

[0071] The color developing solution was purchased from Mecowand Biotechnology.

[0072] The stop solution is 0.5 mol / L H2SO4 solution.

[0073] The 10-fold concentrated washing solution is 0.02 mol / L sodium dihydrogen phosphate, 0.08 mol / L sodium dihydrogen phosphate, 1.37 mol / L sodium chloride and 0.5% (v / v) Tween-20, pH=7.4.

[0074] The self-built duck viral enteritis virus antibody ELISA kit is used for detection, and the detection steps are as follows:

[0075] The serum to be tested was diluted 1:100 times with serum diluent, and 100uL was added to the antigen-coated plate, and duck viral enteritis virus positive control serum and negative control serum were set as controls. The antigen-coated plate was reacted at 37℃ for 15min; washed 5 times with washing solution, and sheep anti-duck IgG antibody labeled with horseradish peroxidase diluted 5000 times with 5% BSA-PBST was added, and incubated at 37℃ for 15min; washed 5 times with washing solution, and color development solution was added. After reacting at 37℃ in the dark for 15min, the stop solution was added, and the OD value was detected by enzyme-linked immunosorbent assay.

[0076] 50 known antibody positive samples collected were detected by using duck viral enteritis virus chemiluminescent ELISA antibody detection kit (experimental group) and self-built duck viral enteritis antibody ELISA kit (control group) (coating protein is the same as the coating protein of the kit of the present invention), and the results showed that all the samples were detected by the chemiluminescent kit, and 42 samples were detected by the self-built duck viral enteritis antibody ELISA kit. The detection rate of the chemiluminescent kit for positive samples was higher than that of the self-built duck viral enteritis antibody ELISA kit. The specific results are shown in Table 3.

[0077] Table 3 Test results of known positive samples

[0078]

[0079]

[0080]

[0081] Example 8

[0082] Comparison of the sensitivity of duck viral enteritis virus chemiluminescent ELISA antibody detection kit (experimental group) and self-built duck viral enteritis antibody ELISA kit (control group, composition and detection method are the same as Example 7) to duck viral enteritis virus positive serum:

[0083] The duck viral enteritis virus positive serum was diluted with serum diluent in multiples, and the gradients were 1:32, 1:64, 1:128, 1:256, 1:512, 1:1024, and 1:2048. The samples of each dilution were detected by using duck viral enteritis virus chemiluminescent ELISA antibody detection kit and self-built duck viral enteritis antibody ELISA kit. Results The sensitivity of the chemiluminescent kit for detecting duck viral enteritis virus antibodies can reach 1:1024, and the sensitivity of the self-built duck viral enteritis antibody ELISA kit for detecting duck viral enteritis virus antibodies can reach 1:512. The chemiluminescent kit has higher sensitivity. The specific results are shown in Table 4.

[0084] Table 4 Sensitivity comparison results

[0085] Sample name Results of the experimental group Results of the control group Duck viral enteritis virus positive serum 1:32 Positive Positive Duck viral enteritis virus positive serum 1:64 Positive Positive Duck viral enteritis virus positive serum 1:128 Positive Positive Duck viral enteritis virus positive serum 1:256 Positive Positive Duck viral enteritis virus positive serum 1:512 Positive Positive Duck viral enteritis virus positive serum 1:1024 Positive Negative Duck viral enteritis virus positive serum 1:2048 Negative Negative

[0086] The above-mentioned embodiments only express several implementation methods of the present invention, which is convenient for understanding the technical solution of the present invention in detail, but it cannot be understood as limiting the scope of the invention patent protection. It should be pointed out that for ordinary technicians in this field, several modifications and improvements can be made without departing from the concept of the present invention, which all belong to the protection scope of the present invention.

Claims

1. A detection kit, characterized in that: The invention comprises a coating solution, a coating plate, an enzyme-labeled secondary antibody, a sample diluent, a positive control serum, a negative control serum, a luminescent substrate and a washing solution. The coating solution uses a carbonate buffer solution with a pH value of 9.2-9.8 as a basic solvent, and the added antigens are composed of 0.9-1.1 μg / ml of gB protein and 0.9-1.1 μg / ml of gC protein; the gB protein is obtained by gene expression of the nucleotide sequence shown in SEQ ID NO.1; the gC protein is obtained by gene expression of the nucleotide sequence shown in SEQ ID NO. NO.2 is obtained by gene expression of the nucleotide sequence shown in FIG. 2; the enzyme-labeled secondary antibody is a goat anti-duck IgG antibody labeled with horseradish peroxidase, and the dilution multiple is 1:10000; the sample diluent is a phosphate buffer containing casein and Tween-20; based on the volume of the phosphate buffer as 100 vol%, the casein content is 0.4-0.6 vol%, and the Tween-20 content is 0.4-0.6% vol%; the luminescent substrate includes a luminescent substrate A and a luminescent substrate B; the luminescent substrate A is based on a Tris buffer with a pH value of 7.5-8.5 and a concentration of 0.04-0.06 mol / L, and 0.08-0.12 mmol / L is added The luminescent substrate B is based on an ammonium acetate solution with a pH value of 5.0-5.5 and a concentration of 0.04-0.06 mol / L, and is added with 0.06-0.08 mmol / L of vitamin C and 2.7-3.3 mmol / L of amino acid oxidase; the washing solution, based on a 10-fold concentration, includes 0.018-0.022 mol / L of sodium dihydrogen phosphate, 0.07-0.09 mol / L of sodium hydrogen phosphate, 1.29-1.45 mol / L of sodium chloride and 0.4-0.6 vol% of Tween-20; the washing solution, based on a 10-fold concentration, has a pH value of 7.3-7.

5.

2. Use of the detection kit according to claim 1 in detecting duck viral enteritis virus for non-disease diagnosis purposes, characterized in that: The application includes detecting whether duck viral enteritis virus is contained in vaccine products, blood products or poultry processed products.

3. The application according to claim 2, characterized in that: The steps include: S1. After the sample is diluted with sample diluent, it is added to the coated plate for reaction; S2, washing the coated plate after the reaction in step S1 with a washing solution, adding an enzyme-labeled secondary antibody, and incubating; S3, washing the coated plate after incubation in step S2 with a washing solution, adding a luminescent substrate, and detecting the luminescence value using a chemiluminescent immunoassay detection instrument; S4. According to the luminescence value obtained in step S3, judging whether the test sample contains duck viral enteritis virus; The determination method in step S4 includes: The S / P value was calculated according to the formula: S / P value = (luminescence value of the test sample - luminescence value of the negative control serum sample) / (luminescence value of the positive control serum sample - luminescence value of the negative control serum sample); If the S / P value is less than 0.47, it is determined that the sample does not contain duck viral enteritis virus; if the S / P value is ≥ 0.47, it is determined that the sample contains duck viral enteritis virus.